Notoamide I

Details

Top
Internal ID 9969a1c7-0368-4c26-8e7d-6862966ea1d5
Taxonomy Organoheterocyclic compounds > Quinolines and derivatives > Pyrroloquinolines
IUPAC Name (1R,17S,19S)-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-3(15),4(13),5,7(12),10-pentaene-2,24,26-trione
SMILES (Canonical) CC1(C=CC2=C(O1)C=CC3=C2NC4=C3C(=O)C56C(C4(C)C)CC7(CCCN7C5=O)C(=O)N6)C
SMILES (Isomeric) CC1(C=CC2=C(O1)C=CC3=C2NC4=C3C(=O)[C@]56[C@H](C4(C)C)C[C@@]7(CCCN7C5=O)C(=O)N6)C
InChI InChI=1S/C26H27N3O4/c1-23(2)10-8-13-15(33-23)7-6-14-17-19(27-18(13)14)24(3,4)16-12-25-9-5-11-29(25)22(32)26(16,20(17)30)28-21(25)31/h6-8,10,16,27H,5,9,11-12H2,1-4H3,(H,28,31)/t16-,25-,26+/m0/s1
InChI Key CDJZXTFDGOKTOT-MEMLUFBQSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C26H27N3O4
Molecular Weight 445.50 g/mol
Exact Mass 445.20015635 g/mol
Topological Polar Surface Area (TPSA) 91.50 Ų
XlogP 3.10
Atomic LogP (AlogP) 3.08
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
CHEMBL518633
J2.582.399K
(1R,17S,19S)-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-3(15),4(13),5,7(12),10-pentaene-2,24,26-trione

2D Structure

Top
2D Structure of Notoamide I

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9778 97.78%
Caco-2 - 0.7385 73.85%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.6740 67.40%
OATP2B1 inhibitior - 0.8578 85.78%
OATP1B1 inhibitior + 0.8765 87.65%
OATP1B3 inhibitior + 0.9265 92.65%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.7570 75.70%
BSEP inhibitior + 0.8902 89.02%
P-glycoprotein inhibitior + 0.7366 73.66%
P-glycoprotein substrate + 0.6554 65.54%
CYP3A4 substrate + 0.6689 66.89%
CYP2C9 substrate - 0.6048 60.48%
CYP2D6 substrate - 0.8587 85.87%
CYP3A4 inhibition - 0.7297 72.97%
CYP2C9 inhibition - 0.7054 70.54%
CYP2C19 inhibition - 0.6992 69.92%
CYP2D6 inhibition - 0.8396 83.96%
CYP1A2 inhibition - 0.7436 74.36%
CYP2C8 inhibition - 0.5798 57.98%
CYP inhibitory promiscuity - 0.5774 57.74%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.6325 63.25%
Eye corrosion - 0.9901 99.01%
Eye irritation - 0.9612 96.12%
Skin irritation - 0.8093 80.93%
Skin corrosion - 0.9413 94.13%
Ames mutagenesis + 0.5630 56.30%
Human Ether-a-go-go-Related Gene inhibition + 0.8260 82.60%
Micronuclear + 0.7700 77.00%
Hepatotoxicity - 0.6250 62.50%
skin sensitisation - 0.8723 87.23%
Respiratory toxicity + 0.7778 77.78%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.9000 90.00%
Nephrotoxicity - 0.7741 77.41%
Acute Oral Toxicity (c) III 0.6583 65.83%
Estrogen receptor binding + 0.7145 71.45%
Androgen receptor binding + 0.7491 74.91%
Thyroid receptor binding + 0.6635 66.35%
Glucocorticoid receptor binding + 0.6148 61.48%
Aromatase binding + 0.7176 71.76%
PPAR gamma + 0.6132 61.32%
Honey bee toxicity - 0.7700 77.00%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.6200 62.00%
Fish aquatic toxicity + 0.9712 97.12%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 99.06% 94.45%
CHEMBL2581 P07339 Cathepsin D 98.09% 98.95%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 97.21% 93.40%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 96.61% 96.77%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 93.93% 85.14%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.72% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.61% 91.11%
CHEMBL1937 Q92769 Histone deacetylase 2 92.09% 94.75%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.08% 97.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.96% 97.25%
CHEMBL3192 Q9BY41 Histone deacetylase 8 91.10% 93.99%
CHEMBL255 P29275 Adenosine A2b receptor 90.63% 98.59%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.13% 95.56%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 89.56% 93.04%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 89.43% 99.23%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.71% 89.00%
CHEMBL4208 P20618 Proteasome component C5 87.68% 90.00%
CHEMBL3310 Q96DB2 Histone deacetylase 11 87.00% 88.56%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 84.07% 94.80%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.05% 100.00%
CHEMBL4225 P49760 Dual specificity protein kinase CLK2 83.98% 80.96%
CHEMBL2916 O14746 Telomerase reverse transcriptase 83.41% 90.00%
CHEMBL4829 O00763 Acetyl-CoA carboxylase 2 83.17% 98.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.63% 95.89%
CHEMBL2378 P30307 Dual specificity phosphatase Cdc25C 82.46% 96.67%
CHEMBL3012 Q13946 Phosphodiesterase 7A 80.70% 99.29%

Cross-Links

Top
PubChem 25180708
NPASS NPC244543
LOTUS LTS0185898
wikiData Q77310200